CN Patent

CN111246841B — 包含阿片样物质受体激动剂作为活性成分的药物制剂、其制备方法和治疗用途

Assigned to Chiesi Farmaceutici SpA · Expires 2024-07-26 · 2y expired

What this patent protects

本发明涉及用于舌下和含服施用的呈水溶液形式的药物制剂，其用于治疗新生儿戒断综合征，所述制剂包含丁丙诺啡或其药学上可接受的盐作为唯一活性成分、粘度增强剂和提供5.0‑7.0的pH的量的缓冲剂。

USPTO Abstract

本发明涉及用于舌下和含服施用的呈水溶液形式的药物制剂，其用于治疗新生儿戒断综合征，所述制剂包含丁丙诺啡或其药学上可接受的盐作为唯一活性成分、粘度增强剂和提供5.0‑7.0的pH的量的缓冲剂。

Drugs covered by this patent

Patent Metadata

Patent number
CN111246841B
Jurisdiction
CN
Classification
—
Expires
2024-07-26
Drug substance claim
No
Drug product claim
No
Assignee
Chiesi Farmaceutici SpA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.